1.        Storto, M.; de Grazia, U.; Knöpfel, T.; Canonico, P. L.; Copani, A.; Richelmi, P.; Nicoletti, F.; Vairetti, M. Selective blockade of mGlu5 metabotropic glutamate receptors protects rat hepatocytes against hypoxic damage. Hepatology 2000, 31, 649–55, doi:10.1002/hep.510310315.

2.        Storto, M.; Battaglia, G.; Gradini, R.; Bruno, V.; Nicoletti, F.; Vairetti, M. Mouse hepatocytes lacking mGlu5 metabotropic glutamate receptors are less sensitive to hypoxic damage. Eur. J. Pharmacol. 2004, 497, 25–7, doi:10.1016/j.ejphar.2004.06.023.

3.        Ferrigno, A.; Berardo, C.; Di Pasqua, L. G.; Siciliano, V.; Richelmi, P.; Nicoletti, F.; Vairetti, M. Selective blockade of the metabotropic glutamate receptor mGluR5 protects mouse livers in in vitro and ex vivo models of ischemia reperfusion injury. Int. J. Mol. Sci. 2018, 19, doi:10.3390/ijms19020314.

4.        Storto, M.; Ngomba, R. T.; Battaglia, G.; Freitas, I.; Griffini, P.; Richelmi, P.; Nicoletti, F.; Vairetti, M. Selective blockade of mGlu5 metabotropic glutamate receptors is protective against acetaminophen hepatotoxicity in mice. J. Hepatol. 2003, 38, 179–87.

5.        Ferrigno, A.; Berardo, C.; Di Pasqua, L. L. G.; Cagna, M.; Siciliano, V.; Richelmi, P.; Vairetti, M. The selective blockade of metabotropic glutamate receptor-5 attenuates fat accumulation in an in vitro model of benign steatosis. Eur. J. Histochem. 2020, In Press, 285–293, doi:10.4081/EJH.2020.3175.

6.        Berardo, C.; Cagna, M.; Di Pasqua, L. G.; Croce, A. C.; Nicoletti, F.; Vairetti, M.; Ferrigno, A. mGluR5 selective blockade reduces oxidative stress and lipid accumulation in obese-high fat diet mice. In Taormina 2021 - 10th INTERNATIONAL MEETING ON METABOTROPIC GLUTAMATE RECEPTORS; 2021.

7.        Di Pasqua, L. G.; Cagna, M.; Berardo, C.; Croce, A. C.; Nicoletti, F.; Vairetti, M.; Ferrigno, A. MPEP, an mGlu5 receptor allosteric modulator, reduces hepatic steatosis in obese high-fat-diet mice. J. Hepatol. 2022, 77, S697, doi:10.1016/s0168-8278(22)01711-1.

8.        Ferrigno, A.; Vairetti, M.; Ambrosi, G.; Rizzo, V.; Richelmi, P.; Blandini, F.; Fuzzati-Armentero, M.-T.; Armentero, M.-T. Selective blockade of mGlu5 metabotropic glutamate receptors is protective against hepatic mitochondrial dysfunction in 6-OHDA lesioned Parkinsonian rats. Clin. Exp. Pharmacol. Physiol. 2015, 42, 695–703, doi:10.1111/1440-1681.12410.

9.        Ferrigno, A.; Di Pasqua, L. G.; Rizzo, V.; Croce, A. C.; Bottiroli, G.; Richelmi, P.; Vairetti, M. Changes in serum levels of asymmetric-dimethylarginine (ADMA) in a rat model of non-alcoholic steatohepatitis: Role of oxidative stress. Dig. Liver Dis. 2014, 46, e27–e28, doi:10.1016/j.dld.2014.01.064.

10.      Ferrigno, A.; Di Pasqua, L. G. L. G.; Berardo, C.; Rizzo, V.; Richelmi, P.; Vairetti, M. Changes in Biliary Levels of Arginine and its Methylated Derivatives after Hepatic Ischaemia/Reperfusion. Basic Clin. Pharmacol. Toxicol. 2016, 119, 101–109, doi:10.1111/bcpt.12540.

11.      Ferrigno, A.; Di Pasqua, L. G.; Berardo, C.; Siciliano, V.; Rizzo, V.; Adorini, L.; Richelmi, P.; Vairetti, M. The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury. PLoS One 2018, 13, doi:10.1371/journal.pone.0191430.

12.      Di Pasqua, L. G.; Berardo, C.; Rizzo, V.; Adorini, L.; Richelmi, P.; Vairetti, M.; Ferrigno, A. The Farnesoid-X-Receptor Agonist Obeticholic Acid Further Increases Biliary Excretion of Asymmetric Dimethylarginine during Hepatic Ischemia/Reperfusion Injury. J. Hepatol. 2016, 64, S315, doi:10.1016/S0168-8278(16)00423-2.

13.      Di Pasqua, L. G.; Berardo, C.; Rizzo, V.; Richelmi, P.; Croce, A. C.; Vairetti, M.; Ferrigno, A. MCD diet-induced steatohepatitis is associated with alterations in asymmetric dimethylarginine (ADMA) and its transporters. Mol. Cell. Biochem. 2016, 419, 147–155, doi:10.1007/s11010-016-2758-2.

14.      Cagna, M.; Palladini, G.; Di Pasqua, L. G.; Croce, A. C.; Adorini, L.; Ferrigno, A.; Vairetti, M. Obeticholic acid reduces hepatic matrix metalloproteinase activity in a diet-induced ob/ob mouse model of NASH. J. Hepatol. 2022, 77, S702, doi:10.1016/s0168-8278(22)01720-2.